AI assistant
Korro Bio, Inc. — Director's Dealing 2024
Apr 24, 2024
33032_dirs_2024-04-24_a3705337-14ef-46ee-b443-0c5576f43d62.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Korro Bio, Inc. (KRRO)
CIK: 0001703647
Period of Report: 2024-04-22
Reporting Person: Behbahani Ali (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-22 | Common Stock | A | 17857 | $56 | Acquired | 1090793 | Indirect |
Footnotes
F1: Acquired from the Issuer on April 22, 2024 pursuant to a Subscription Agreement dated April 17, 2024.
F2: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.